MIRA — Mira Pharmaceuticals Balance Sheet
0.000.00%
- $20.51m
- $17.68m
Annual balance sheet for Mira Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.003 | 2.81 | 0.351 | 4.6 | 2.83 |
Net Total Receivables | — | — | — | 0.012 | — |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.003 | 2.91 | 0.494 | 4.86 | 2.89 |
Net Property, Plant And Equipment | — | — | 0.364 | 0.005 | 0 |
Long Term Notes Receivable | |||||
Total Assets | 0.022 | 3.36 | 0.858 | 4.93 | 2.92 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.09 | 1.09 | 1.37 | 0.558 | 0.723 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.09 | 1.09 | 1.45 | 0.558 | 0.723 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -0.068 | 2.26 | -0.596 | 4.37 | 2.2 |
Total Liabilities & Shareholders' Equity | 0.022 | 3.36 | 0.858 | 4.93 | 2.92 |
Total Common Shares Outstanding |